Søren Møller

Director of Investments presso

Novo Seeds

58 anni

77 relazioni

Health Technology

Finance

Commercial Services

Profilo

Søren Møller is currently Director at Dansk Biotek, Reapplix A, Galecto Biotech ApS, Forendo Pharma Oy, Advanced MR Analytics AB, Biosyntia ApS, NorthSea Therapeutics BV, and Ejendomsselskabet Hvidovre Torv AS.
Managing Partner at Novo Seeds since 2011.
Managing Partner at Novo Planetary Health.
Managing Partner at Novo Holdings A since 2011.
Former Vice Chairman at Danske Spil A. Former Chairman at Affinicon ApS.
Former Director at Livingston International, Inc., Denator AB, EpiTherapeutics ApS, and RSPR Pharma AB. Independent Director at Damora Therapeutics, Inc. from 2020 to 2024.
Global Manager-Bioinformatics & Genomics at Novozymes A from 2010 to 2015.
Head-Lead Identification at Noapab Holdings A. Chief Scientific Officer at Exiqon A from 2010 to 2015.
Education includes a doctorate (1997) and graduate degree (1993) from the Technical University of Denmark.

Posizioni attive di Søren Møller

Società	Posizione	Inizio
Novo Seeds Novo Seeds Investment ManagersFinance Novo Seeds invests in companies located in Europe and the United States. The fund targets companies operating in the fields of life science and healthcare technology sectors. It provides financing for seed and early stage capital requirement.	Director of Investments	01/10/2011
Reapplix A/S Reapplix A/S Medical SpecialtiesHealth Technology Manufactures wound healing patches made from patient's blood that for the biological treatment and management of diabetic foot ulcers	Direttore/Membro del Consiglio	-
Biosyntia ApS Biosyntia ApS BiotechnologyHealth Technology Provides services in synthetic biology and metabolic engineering fields	Direttore/Membro del Consiglio	-
Dansk Biotek Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Operates as an industry association for biotech companies with promoting the biotechnological research	Direttore/Membro del Consiglio	-
Galecto Biotech ApS Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Manufactures galectin modulators for the treatment of severe diseases which includes fibrosis and cancer	Direttore/Membro del Consiglio	-
NorthSea Therapeutics BV NorthSea Therapeutics BV BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel strategies for the treatment of metabolic, inflammatory and fibrotic diseases	Direttore/Membro del Consiglio	-
Forendo Pharma Oy Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage drug company that develops novel treatments in women’s health	Direttore/Membro del Consiglio	-
Advanced MR Analytics AB Advanced MR Analytics AB Medical/Nursing ServicesHealth Services Provides AI-enhanced MRI-based body composition analytics delivering services	Direttore/Membro del Consiglio	-
Novo Holdings A/S (Denmark) Novo Holdings A/S (Denmark) Investment ManagersFinance Functions as an alternative investment manager	Corporate Officer/Principal	01/01/2011
░░░░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░ ░░	░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░	-

Tutte le posizioni attive di Søren Møller

Precedenti posizioni note di Søren Møller

Società	Posizione	Fine
░░░░░░ ░░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░	░░░░░░░░░░
░░░░░░░░░ ░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░ ░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░ ░░░░░░░░ ░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-
░░░░░░░░░ ░░░	░░░░░░░░░░	-

Vedi nel dettaglio l'esperienza di Søren Møller

Formazione di Søren Møller

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Søren Møller

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	21
Novozymes A/S Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals	Process Industries
Novo Holdings A/S (Denmark) Novo Holdings A/S (Denmark) Investment ManagersFinance Functions as an alternative investment manager	Finance
Livingston International, Inc. Livingston International, Inc. Air Freight/CouriersTransportation Provides customs brokerage, transportation and integrated logistics services	Transportation
Noapab Holdings A/S Noapab Holdings A/S Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and diagnostics products	Commercial Services
Technical University of Denmark Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Exiqon A/S Exiqon A/S Miscellaneous Commercial ServicesCommercial Services Engages in the pharmaceutical industry	Commercial Services
Denator AB Denator AB Medical SpecialtiesHealth Technology Provides instruments and consumables that stabilize biological samples	Health Technology
EpiTherapeutics ApS EpiTherapeutics ApS Pharmaceuticals: MajorHealth Technology Develops cancer drugs based on epigenetics	Health Technology
Dansk Biotek Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Operates as an industry association for biotech companies with promoting the biotechnological research	Commercial Services
Novo Seeds Novo Seeds Investment ManagersFinance Novo Seeds invests in companies located in Europe and the United States. The fund targets companies operating in the fields of life science and healthcare technology sectors. It provides financing for seed and early stage capital requirement.	Finance
RSPR Pharma AB RSPR Pharma AB Pharmaceuticals: MajorHealth Technology Develops therapeutics for inflammatory vascular diseases	Health Technology
Danske Spil A/S Danske Spil A/S Media ConglomeratesConsumer Services Provides lotteries and gambling services	Consumer Services
Reapplix A/S Reapplix A/S Medical SpecialtiesHealth Technology Manufactures wound healing patches made from patient's blood that for the biological treatment and management of diabetic foot ulcers	Health Technology
Galecto Biotech ApS Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Manufactures galectin modulators for the treatment of severe diseases which includes fibrosis and cancer	Health Technology
Forendo Pharma Oy Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage drug company that develops novel treatments in women’s health	Health Technology
Affinicon ApS Affinicon ApS Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products	Health Technology
Advanced MR Analytics AB Advanced MR Analytics AB Medical/Nursing ServicesHealth Services Provides AI-enhanced MRI-based body composition analytics delivering services	Health Services
Biosyntia ApS Biosyntia ApS BiotechnologyHealth Technology Provides services in synthetic biology and metabolic engineering fields	Health Technology
NorthSea Therapeutics BV NorthSea Therapeutics BV BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel strategies for the treatment of metabolic, inflammatory and fibrotic diseases	Health Technology
Galecto, Inc. Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases	Health Technology
Ejendomsselskabet Hvidovre Torv AS Ejendomsselskabet Hvidovre Torv AS Real Estate DevelopmentFinance Engages in rental of commercial real estate properties	Finance